Effects of APOE ɛ4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment

[1]  Daniel Weintraub,et al.  APOE ε4 increases risk for dementia in pure synucleinopathies. , 2013, JAMA neurology.

[2]  C. Ayata,et al.  Cerebrovascular lesions induce transient β-amyloid deposition. , 2011, Brain : a journal of neurology.

[3]  J. S. Kim,et al.  Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B , 2011, Neurology.

[4]  Dong Won Yang,et al.  APOE ε4 allele status in korean dementia patients with severe white matter hyperintensities. , 2011, Journal of Alzheimer's disease : JAD.

[5]  C. Rowe,et al.  Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging , 2010, Neurobiology of Aging.

[6]  Sang Won Seo,et al.  Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients , 2010, Journal of Korean medical science.

[7]  Maria C. Norton,et al.  Association between APOE ε4 Allele and Vascular Dementia: The Cache County Study , 2010, Dementia and Geriatric Cognitive Disorders.

[8]  S. Cho,et al.  Subcortical Vascular versus Amnestic Mild Cognitive Impairment: Comparison of Cerebral Glucose Metabolism , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[9]  Jeffrey A. James,et al.  Amyloid imaging in mild cognitive impairment subtypes , 2009, Annals of neurology.

[10]  M Schwaiger,et al.  Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease , 2009, Neurology.

[11]  K. Blennow,et al.  Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis , 2008, Journal of the Neurological Sciences.

[12]  M. Nieminen,et al.  Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[13]  Norbert Schuff,et al.  Neuropathological basis of magnetic resonance images in aging and dementia , 2008, Annals of neurology.

[14]  P. Pasqualetti,et al.  What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia? , 2007, European journal of neurology.

[15]  Jong-Min Lee,et al.  Cortical thickness in single- versus multiple-domain amnestic mild cognitive impairment , 2007, NeuroImage.

[16]  C. Sudlow,et al.  Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  D. Mann,et al.  Apolipoprotein E υ4 Allele Frequency in Vascular Dementia , 2006, Dementia and Geriatric Cognitive Disorders.

[18]  D. Mann,et al.  Apolipoprotein E epsilon4 allele frequency in vascular dementia. , 2006, Dementia and geriatric cognitive disorders.

[19]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[20]  C. Enzinger,et al.  Apolipoprotein E ε4 is associated with rapid progression of multiple sclerosis , 2001, Neurology.

[21]  D. Levy,et al.  Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. , 2001, Atherosclerosis.

[22]  C. Enzinger,et al.  Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. , 2001, Neurology.

[23]  O. Paulson,et al.  Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate , 2000, Multiple sclerosis.

[24]  M. Owen,et al.  APOE ε4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome , 2000, British Journal of Psychiatry.

[25]  G C Roman,et al.  Research criteria for subcortical vascular dementia in clinical trials. , 2000, Journal of neural transmission. Supplementum.

[26]  Linda Teri,et al.  Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series , 1999, Journal of the American Geriatrics Society.

[27]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[28]  R N Kalaria,et al.  Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. , 1996, The American journal of pathology.

[29]  R. Sulkava,et al.  APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+ , 1996, Neurobiology of Aging.

[30]  R. Katzman.,et al.  Apolipoprotein-epsilon4 and head trauma: Synergistic or additive risks? , 1996, Neurology.

[31]  B. Tycko,et al.  Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease , 1995, Neurology.

[32]  E. Perry,et al.  Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. , 1994, The American journal of pathology.

[33]  P. Amouyel,et al.  The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease , 1994, The Lancet.

[34]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[35]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[36]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[37]  M. Lawton,et al.  Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .